BFB Health Limited (HKG:0205)
Hong Kong · Delayed Price · Currency is HKD 0.5250
+0.0200 (3.96%)
Sep 3, 2026, 3:48 PM HKT
BFB Health Income Statement
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 301.1 | 33.12 | 30.15 | 38.38 | 73.16 | 68.35 | |
Revenue Growth | 885.14% | 9.84% | -21.44% | -47.54% | 7.04% | -14.74% |
Cost of Revenue | 172.81 | 16.88 | 17.74 | 27.15 | 31.92 | 26.69 |
Gross Profit | 128.29 | 16.23 | 12.42 | 11.23 | 41.24 | 41.66 |
Selling, General & Admin | 112.65 | 19.82 | 24.79 | 47.89 | 25.14 | 28.95 |
Operating Expenses | 124.93 | 32.1 | 49.97 | 45.7 | 25.14 | 28.95 |
Operating Income | 3.36 | -15.87 | -37.55 | -34.47 | 16.1 | 12.71 |
Interest Expense | -1.82 | -2.01 | -1.92 | -1.86 | -1.68 | -2.3 |
Interest & Investment Income | 0.06 | 0.06 | 0.08 | 0.45 | 0.2 | 0.01 |
Earnings From Equity Investments | 1.6 | 1.7 | -22.53 | -5.27 | -2.71 | -11.59 |
Currency Exchange Gain (Loss) | -2.59 | -0.22 | 1.84 | 2.69 | 16.15 | -7.18 |
Other Non Operating Income (Expenses) | -3.47 | -3.75 | -6.5 | -6.15 | 2.47 | 1.47 |
EBT Excluding Unusual Items | -2.85 | -20.08 | -66.59 | -44.61 | 30.53 | -6.87 |
Gain (Loss) on Sale of Investments | 38.9 | 44.8 | 9.91 | 12.12 | -118.04 | -36.67 |
Gain (Loss) on Sale of Assets | -0.04 | -0.04 | 6.78 | 17.57 | -0.1 | - |
Asset Writedown | - | - | -9.53 | - | - | - |
Other Unusual Items | -44.25 | -44.25 | 30.03 | -25.55 | 0.32 | - |
Pretax Income | -8.23 | -19.57 | -29.4 | -40.47 | -87.29 | -43.54 |
Income Tax Expense | 1.62 | 0.43 | -0.52 | -3.07 | 1.97 | 1.05 |
Earnings From Continuing Operations | -9.85 | -19.99 | -28.88 | -37.4 | -89.26 | -44.59 |
Minority Interest in Earnings | 14.37 | 14.45 | -5.71 | 14.12 | 6.79 | 4.46 |
Net Income | 4.52 | -5.54 | -34.6 | -23.28 | -82.47 | -40.14 |
Net Income to Common | 4.52 | -5.54 | -34.6 | -23.28 | -82.47 | -40.14 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,089 | 947 | 736 | 736 | 656 | 511 |
Shares Outstanding (Diluted) | 1,103 | 958 | 736 | 736 | 656 | 511 |
Shares Change | 49.87% | 30.20% | - | 12.23% | 28.26% | 46.81% |
EPS (Basic) | 0.00 | -0.01 | -0.05 | -0.03 | -0.13 | -0.08 |
EPS (Diluted) | 0.00 | -0.01 | -0.05 | -0.03 | -0.13 | -0.08 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -23.88 | 22.95 | -36.8 | -7.83 | -22.85 |
Free Cash Flow Per Share | - | -0.03 | 0.03 | -0.05 | -0.01 | -0.04 |
Gross Margin | 42.61% | 49.02% | 41.18% | 29.26% | 56.37% | 60.95% |
Operating Margin | 1.12% | -47.92% | -124.55% | -89.82% | 22.01% | 18.59% |
Profit Margin | 1.50% | -16.73% | -114.74% | -60.66% | -112.73% | -58.72% |
Free Cash Flow Margin | - | -72.10% | 76.13% | -95.89% | -10.70% | -33.43% |
EBITDA | 3.81 | -15.57 | -37.25 | -34.21 | 16.54 | 13.58 |
EBITDA Margin | 1.26% | -47.02% | -123.54% | -89.14% | 22.61% | 19.86% |
D&A For EBITDA | 0.44 | 0.3 | 0.3 | 0.26 | 0.44 | 0.87 |
EBIT | 3.36 | -15.87 | -37.55 | -34.47 | 16.1 | 12.71 |
EBIT Margin | 1.12% | -47.92% | -124.55% | -89.82% | 22.01% | 18.59% |